# Federal Register #2026-22725

BIS seeks comments on specialty pharmaceutical import tariff information collection

**Buyer:** Department of Commerce, Bureau of Industry and Security
**Posted:** November 06, 2026
**Respond By:** January 06, 2027
**Identifier:** 2026-22725

The Department of Commerce is seeking comments on a specialty-pharmaceutical import tariff information collection, not procuring products or services.
- **Government buyer:** U.S. Department of Commerce, Bureau of Industry and Security (BIS).
- **Purpose:** Gather comments on information BIS would collect from companies seeking a zero-percent tariff rate for qualifying specialty pharmaceuticals and related ingredients under Section 232 adjustments.
- **Requested information:** Organization details; product description and HTSUS classification; country of origin; importer of record; and evidence of an urgent U.S. health need, including the disease treated, alternative therapies, and estimated number of domestic patients.
- **Estimated reporting burden:** 250 respondents, one response per year, eight hours per response, and 2,000 total annual burden hours. OMB Control Number 0694-0150.
- **Procurement details:** No products, services, OEMs, vendors, quantities, or contract value are identified.

### Description

The Department of Commerce invites public and federal agency comments on an information collection under the Paperwork Reduction Act. The notice provides a 60-day comment period for the OMB-approved emergency collection associated with Section 232 adjustments to imports of specialty pharmaceuticals and related ingredients. Companies seeking a zero-percent tariff rate for qualifying products must submit information about their organization, the imported product, and how it meets an urgent health need. Comments are due January 5, 2027.

[View original listing](https://www.federalregister.gov/documents/2026/11/06/2026-22725/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-omb-for)